R&D | February 07, 2026
£1bn London Cancer Hub expansion wins planning approval
The approved scheme will deliver around 1 million sq ft of state-of-the-art laboratory and research space across a 12-acre site
The approved scheme will deliver around 1 million sq ft of state-of-the-art laboratory and research space across a 12-acre site
The program seeks to boost regulatory predictability, support construction of US-based manufacturing sites
The trial aims to assess the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of the combination therapy
Sabitha highlighted the growing relevance of minimally invasive therapies in modern medicine
CHOMax integrates cell line development, process development, analytics, and GMP manufacturing under robust quality processes
The work will leverage ProBioGen’s CHO.RiGHT expression platform, powered by its proprietary DirectedLuck transposase technology, alongside PsiBot smart automation
Within India, Dabur expects its Home & Personal Care business to deliver double-digit growth,
Motiva, SmoothSilk, Round and Ergonomix implants represent the latest in plastic surgery innovation
Masitinib targets mast cells, which play a critical role in severe forms of SCD and its complications, including vaso-occlusive crises, acute chest syndrome, and pain
The system is intended for some of the tiniest patients—premature infants weighing as little as two pounds
Subscribe To Our Newsletter & Stay Updated
